{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:22:33Z","timestamp":1783977753678,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-023-02592-x","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T19:01:44Z","timestamp":1686250904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of Child-Friendly Lisdexamfetamine Chewable Tablets Using Ion Exchange Resin as a Taste-Masking Carrier Based on the Concept of Quality by Design (QbD)"],"prefix":"10.1208","volume":"24","author":[{"given":"Chunmei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-5801","authenticated-orcid":false,"given":"Haoxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"2","key":"2592_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2165\/00148581-200709020-00007","volume":"9","author":"SK Blick","year":"2007","unstructured":"Blick SK, Keating GM. Lisdexamfetamine. Paediatr Drugs. 2007;9(2):129\u201335; discussion 36-8. https:\/\/doi.org\/10.2165\/00148581-200709020-00007.","journal-title":"Paediatr Drugs."},{"issue":"5","key":"2592_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrd2315","volume":"6","author":"J Elia","year":"2007","unstructured":"Elia J, Easley C, Kirkpatrick P. Lisdexamfetamine dimesylate. Nat Rev Drug Discov. 2007;6(5):343\u20134. https:\/\/doi.org\/10.1038\/nrd2315.","journal-title":"Nat Rev Drug Discov."},{"issue":"1","key":"2592_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2147\/ndt.s9749","volume":"6","author":"M Pennick","year":"2010","unstructured":"Pennick M. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010;6(1):317\u201327. https:\/\/doi.org\/10.2147\/ndt.s9749.","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"2","key":"2592_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.clinthera.2010.02.011","volume":"32","author":"SW Boellner","year":"2010","unstructured":"Boellner SW, Stark JG, Krishnan S, Zhang Y. Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit\/hyperactivity disorder: a single-dose, randomized, open-label, crossover study. Clin Ther. 2010;32(2):252\u201364. https:\/\/doi.org\/10.1016\/j.clinthera.2010.02.011.","journal-title":"Clin Ther."},{"issue":"1","key":"2592_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1185\/030079908x242737","volume":"24","author":"SM Krishnan","year":"2008","unstructured":"Krishnan SM, Stark JG. Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers. Curr Med Res Opin. 2008;24(1):33\u201340. https:\/\/doi.org\/10.1185\/030079908x242737.","journal-title":"Curr Med Res Opin."},{"issue":"7-8","key":"2592_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuropharm.2009.08.020","volume":"57","author":"DJ Heal","year":"2009","unstructured":"Heal DJ, Cheetham SC, Smith SL. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacol. 2009;57(7-8):608\u201318. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.08.020.","journal-title":"Neuropharmacol."},{"issue":"6","key":"2592_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0269881113482532","volume":"27","author":"DJ Heal","year":"2013","unstructured":"Heal DJ, Smith SL, Gosden J, Nutt DJ. Amphetamine, past and present\u2014a pharmacological and clinical perspective. J Psychopharmacol. 2013;27(6):479\u201396. https:\/\/doi.org\/10.1177\/0269881113482532.","journal-title":"J Psychopharmacol."},{"issue":"3","key":"2592_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/s0149-2918(07)80083-x","volume":"29","author":"J Biederman","year":"2007","unstructured":"Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit\/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007;29(3):450\u201363. https:\/\/doi.org\/10.1016\/s0149-2918(07)80083-x.","journal-title":"Clin Ther."},{"issue":"7","key":"2592_CR9","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1124\/dmd.106.009605","volume":"34","author":"HJ Zhu","year":"2006","unstructured":"Zhu HJ, Wang JS, DeVane CL, Williard RL, Donovan JL, Middaugh LD, et al. The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine. Drug Metab Dispos. 2006;34(7):1116\u201321. https:\/\/doi.org\/10.1124\/dmd.106.009605.","journal-title":"Drug Metab Dispos."},{"issue":"4","key":"2592_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/0269881109103113","volume":"23","author":"DR Jasinski","year":"2009","unstructured":"Jasinski DR, Krishnan S. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. J Psychopharmacol. 2009;23(4):419\u201327. https:\/\/doi.org\/10.1177\/0269881109103113.","journal-title":"J Psychopharmacol."},{"issue":"4","key":"2592_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/jphp.12610","volume":"69","author":"P Mistry","year":"2017","unstructured":"Mistry P, Batchelor H, project SP-U. Evidence of acceptability of oral paediatric medicines: a review. J Pharm Pharmacol. 2017;69(4):361\u201376. https:\/\/doi.org\/10.1111\/jphp.12610.","journal-title":"J Pharm Pharmacol."},{"issue":"17","key":"2592_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/s1359-6446(01)01922-5","volume":"6","author":"V Anand","year":"2001","unstructured":"Anand V, Kandarapu R, Garg S. Ion-exchange resins: carrying drug delivery forward. Drug Discov Today. 2001;6(17):905\u201314. https:\/\/doi.org\/10.1016\/s1359-6446(01)01922-5.","journal-title":"Drug Discov Today."},{"key":"2592_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jddst.2018.12.002","volume":"49","author":"X Han","year":"2019","unstructured":"Han X, Zhang S, Chai Z, Dong Y, He W, Yin L, et al. In vitro and in vivo evaluation of the taste-masking efficiency of Amberlite IRP88 as drug carries in chewable tablets. J Drug Deliv Sci Technol. 2019;49:547\u201355. https:\/\/doi.org\/10.1016\/j.jddst.2018.12.002.","journal-title":"J Drug Deliv Sci Technol."},{"issue":"1-2","key":"2592_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijpharm.2013.07.072","volume":"455","author":"JI Kim","year":"2013","unstructured":"Kim JI, Cho SM, Cui JH, Cao QR, Oh E, Lee BJ. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex. Int J Pharm. 2013;455(1-2):31\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.07.072.","journal-title":"Int J Pharm."},{"issue":"1-2","key":"2592_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijpharm.2018.05.068","volume":"547","author":"DCT Tan","year":"2018","unstructured":"Tan DCT, Ong JJ, Gokhale R, Heng PWS. Hot melt extrusion of ion-exchange resin for taste masking. Int J Pharm. 2018;547(1-2):385\u201394. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.05.068.","journal-title":"Int J Pharm."},{"issue":"5","key":"2592_CR16","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/03639045.2016.1224894","volume":"43","author":"AM Rajesh","year":"2017","unstructured":"Rajesh AM, Popat KM. Taste masking of azithromycin by resin complex and sustained release through interpenetrating polymer network with functionalized biopolymers. Drug Dev Ind Pharm. 2017;43(5):732\u201341. https:\/\/doi.org\/10.1080\/03639045.2016.1224894.","journal-title":"Drug Dev Ind Pharm."},{"key":"2592_CR17","unstructured":"EMA: ICH Q8(R2) Guideline \u201cPharmaceutical Development\u201d https:\/\/ich.org\/page\/quality-guidelines (2009). Accessed."},{"issue":"3","key":"2592_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejpb.2006.06.008","volume":"64","author":"P Perez","year":"2006","unstructured":"Perez P, Sune-Negre JM, Minarro M, Roig M, Fuster R, Garcia-Montoya E, et al. A new expert systems (SeDeM diagram) for control batch powder formulation and preformulation drug products. Eur J Pharm Biopharm. 2006;64(3):351\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2006.06.008.","journal-title":"Eur J Pharm Biopharm."},{"key":"2592_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejpb.2019.09.003","volume":"144","author":"L Zieschang","year":"2019","unstructured":"Zieschang L, Klein M, Jung N, Kramer J, Windbergs M. Formulation development of medicated chewing gum tablets by direct compression using the SeDeM-Diagram-Expert-System. Eur J Pharm Biopharm. 2019;144:68\u201378. https:\/\/doi.org\/10.1016\/j.ejpb.2019.09.003.","journal-title":"Eur J Pharm Biopharm."},{"key":"2592_CR20","unstructured":"DEA: Lists of scheduling actions, controlled substances, regulated chemicals. https:\/\/www.deadiversion.usdoj.gov\/schedules\/orangebook\/orangebook.pdf (2022). Accessed April 2022."},{"issue":"1-2","key":"2592_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijpharm.2010.08.042","volume":"400","author":"K Woertz","year":"2010","unstructured":"Woertz K, Tissen C, Kleinebudde P, Breitkreutz J. Rational development of taste masked oral liquids guided by an electronic tongue. Int J Pharm. 2010;400(1-2):114\u201323. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.08.042.","journal-title":"Int J Pharm."},{"issue":"11","key":"2592_CR22","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/ja01203a064","volume":"69","author":"GE Boyd","year":"1947","unstructured":"Boyd GE, Schubert J, Adamson AW. The exchange adsorption of ions from aqueous solutions by organic zeolites; ion-exchange equilibria. J Am Chem Soc. 1947;69(11):2818\u201329. https:\/\/doi.org\/10.1021\/ja01203a064.","journal-title":"J Am Chem Soc."},{"issue":"1-2","key":"2592_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0378-5173(01)00573-7","volume":"216","author":"H Ichikawa","year":"2001","unstructured":"Ichikawa H, Fujioka K, Adeyeye MC, Fukumori Y. Use of ion-exchange resins to prepare 100 \u03bcm-sized microcapsules with prolonged drug-release by the Wurster process. Int J Pharm. 2001;216(1-2):67\u201376. https:\/\/doi.org\/10.1016\/s0378-5173(01)00573-7.","journal-title":"Int J Pharm."},{"issue":"1-2","key":"2592_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2018.05.004","volume":"545","author":"R Shang","year":"2018","unstructured":"Shang R, Liu C, Quan P, Zhao H, Fang L. Effect of drug-ion exchange resin complex in betahistine hydrochloride orodispersible film on sustained release, taste masking and hygroscopicity reduction. Int J Pharm. 2018;545(1-2):163\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.05.004.","journal-title":"Int J Pharm."},{"key":"2592_CR25","doi-asserted-by":"publisher","first-page":"119779","DOI":"10.1016\/j.ijpharm.2020.119779","volume":"588","author":"Y Deng","year":"2020","unstructured":"Deng Y, Wang T, Li J, Sun W, He H, Gou J, et al. Studies on the in vitro ion exchange kinetics and thermodynamics and in vivo pharmacokinetics of the carbinoxamine-resin complex. Int J Pharm. 2020;588:119779. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119779.","journal-title":"Int J Pharm."},{"issue":"3","key":"2592_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1021\/ja01099a022","volume":"75","author":"D Reichenberg","year":"1953","unstructured":"Reichenberg D. Properties of ion-exchange resins in relation to their structure. III. Kinetics of exchange. J Am Chem Soc. 1953;75(3):589\u201397. https:\/\/doi.org\/10.1021\/ja01099a022.","journal-title":"J Am Chem Soc."},{"issue":"9","key":"2592_CR27","doi-asserted-by":"publisher","first-page":"e0203846","DOI":"10.1371\/journal.pone.0203846","volume":"13","author":"I Nofrerias","year":"2018","unstructured":"Nofrerias I, Nardi A, Sune-Pou M, Boeckmans J, Sune-Negre JM, Garcia-Montoya E, et al. Optimization of the cohesion index in the SeDeM diagram expert system and application of SeDeM diagram: an improved methodology to determine the cohesion index. PLoS One. 2018;13(9):e0203846. https:\/\/doi.org\/10.1371\/journal.pone.0203846.","journal-title":"PLoS One."},{"key":"2592_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.powtec.2017.02.019","volume":"312","author":"JC Scholtz","year":"2017","unstructured":"Scholtz JC, Steenekamp JH, Hamman JH, Tiedt LR. The SeDeM expert diagram system: its performance and predictability in direct compressible formulations containing novel excipients and different types of active ingredients. Powder Technol. 2017;312:222\u201336. https:\/\/doi.org\/10.1016\/j.powtec.2017.02.019.","journal-title":"Powder Technol."},{"issue":"3","key":"2592_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ejpb.2009.07.001","volume":"73","author":"JE Aguilar-D\u00edaz","year":"2009","unstructured":"Aguilar-D\u00edaz JE, Garc\u00eda-Montoya E, P\u00e9rez-Lozano P, Su\u00f1e-Negre JM, Mi\u00f1arro M, Tic\u00f3 JR. The use of the SeDeM Diagram expert system to determine the suitability of diluents\u2013disintegrants for direct compression and their use in formulation of ODT. Eur J Pharm Biopharm. 2009;73(3):414\u201323. https:\/\/doi.org\/10.1016\/j.ejpb.2009.07.001.","journal-title":"Eur J Pharm Biopharm."},{"issue":"3","key":"2592_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.ejpb.2008.01.020","volume":"69","author":"JM Sune-Negre","year":"2008","unstructured":"Sune-Negre JM, Perez-Lozano P, Minarro M, Roig M, Fuster R, Hernandez C, et al. Application of the SeDeM diagram and a new mathematical equation in the design of direct compression tablet formulation. Eur J Pharm Biopharm. 2008;69(3):1029\u201339. https:\/\/doi.org\/10.1016\/j.ejpb.2008.01.020.","journal-title":"Eur J Pharm Biopharm."},{"key":"2592_CR31","doi-asserted-by":"crossref","unstructured":"Sune-Negre JM. SeDeM diagram: a new expert system for the formulation of Drugs in solid form. Expert Systems for Human, Materials and Automation. 2011.","DOI":"10.5772\/16540"},{"key":"2592_CR32","unstructured":"FDA: Center for Drug Evaluation and Research (CDER). APPLICATION NUMBER: 208510Orig1s000 CHEMISTRY REVIEW(S). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/208510Orig1s000ChemR.pdf Accessed."},{"key":"2592_CR33","unstructured":"United States Pharmacopeia and the National Formulary (USP-NF). Chapter 711 Dissolution. Rockville; US Pharmacopeial Convention; 2022."},{"issue":"6","key":"2592_CR34","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1208\/s12249-016-0666-0","volume":"18","author":"P Chandrasekaran","year":"2017","unstructured":"Chandrasekaran P, Kandasamy R. Development of oral flexible tablet (OFT) formulation for pediatric and geriatric patients: a novel age-appropriate formulation platform. AAPS PharmSciTech. 2017;18(6):1972\u201386. https:\/\/doi.org\/10.1208\/s12249-016-0666-0.","journal-title":"AAPS PharmSciTech."},{"key":"2592_CR35","unstructured":"FDA: Quality attribute considerations for chewable tablets guidance for industry. https:\/\/www.fda.gov\/media\/98598\/download (2018). Accessed August 2018."},{"issue":"2","key":"2592_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/03639045.2013.858736","volume":"41","author":"A Gupta","year":"2015","unstructured":"Gupta A, Chidambaram N, Khan MA. An index for evaluating difficulty of chewing index for chewable tablets. Drug Dev Ind Pharm. 2015;41(2):239\u201343. https:\/\/doi.org\/10.3109\/03639045.2013.858736.","journal-title":"Drug Dev Ind Pharm."},{"issue":"4","key":"2592_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0308-8146(93)90178-i","volume":"47","author":"W Spillane","year":"1993","unstructured":"Spillane W. Synthesis and taste properties of sodium disubstituted phenylsulfamates. Structure-taste relationships for sweet and bitter\/sweet sulfamates. Food Chem. 1993;47(4):363\u20139. https:\/\/doi.org\/10.1016\/0308-8146(93)90178-i.","journal-title":"Food Chem."},{"issue":"2","key":"2592_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1021\/ci0504418","volume":"46","author":"S Rodgers","year":"2006","unstructured":"Rodgers S, Glen RC, Bender A. Characterizing bitterness: identification of key structural features and development of a classification model. J Chem Inf Model. 2006;46(2):569\u201376. https:\/\/doi.org\/10.1021\/ci0504418.","journal-title":"J Chem Inf Model."},{"issue":"1334","key":"2592_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1098\/rspa.1962.0145","volume":"268","author":"W EGaRE","year":"1997","unstructured":"EGaRE W. The Donnan law and its application to ion exchanger polymers. Proceed Royal Soc London Ser A Math Phys Sci. 1997;268(1334):339\u201349. https:\/\/doi.org\/10.1098\/rspa.1962.0145.","journal-title":"Proceed Royal Soc London Ser A Math Phys Sci."},{"issue":"11","key":"2592_CR40","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/jps.2600611116","volume":"61","author":"SM Blaug","year":"1972","unstructured":"Blaug SM, Huang WT. Interaction of dextroamphetamine sulfate with spray-dried lactose. J Pharm Sci. 1972;61(11):1770\u20135. https:\/\/doi.org\/10.1002\/jps.2600611116.","journal-title":"J Pharm Sci."},{"issue":"4","key":"2592_CR41","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1208\/s12249-011-9677-z","volume":"12","author":"Y Wu","year":"2011","unstructured":"Wu Y, Levons J, Narang AS, Raghavan K, Rao VM. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. AAPS PharmSciTech. 2011;12(4):1248\u201363. https:\/\/doi.org\/10.1208\/s12249-011-9677-z.","journal-title":"AAPS PharmSciTech."},{"issue":"1","key":"2592_CR42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ijpharm.2018.07.025","volume":"548","author":"N Ekmekciyan","year":"2018","unstructured":"Ekmekciyan N, Tuglu T, El-Saleh F, Muehlenfeld C, Stoyanov E, Quodbach J. Competing for water: a new approach to understand disintegrant performance. Int J Pharm. 2018;548(1):491\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.025.","journal-title":"Int J Pharm."},{"issue":"10","key":"2592_CR43","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.xphs.2018.06.008","volume":"107","author":"A Berardi","year":"2018","unstructured":"Berardi A, Bisharat L, Blaibleh A, Pavoni L, Cespi M. A simple and inexpensive image analysis technique to study the effect of disintegrants concentration and diluents type on disintegration. J Pharm Sci. 2018;107(10):2643\u201352. https:\/\/doi.org\/10.1016\/j.xphs.2018.06.008.","journal-title":"J Pharm Sci."},{"key":"2592_CR44","doi-asserted-by":"publisher","first-page":"120206","DOI":"10.1016\/j.ijpharm.2021.120206","volume":"596","author":"Y Deng","year":"2021","unstructured":"Deng Y, Shen L, Yang Y, Shen J. Development of nanoparticle-based orodispersible palatable pediatric formulations. Int J Pharm. 2021;596:120206. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120206.","journal-title":"Int J Pharm."},{"issue":"2","key":"2592_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1208\/s12249-018-1277-8","volume":"20","author":"MRP Rao","year":"2019","unstructured":"Rao MRP, Bhutada K, Kaushal P. Taste evaluation by electronic tongue and bioavailability enhancement of efavirenz. AAPS PharmSciTech. 2019;20(2):56. https:\/\/doi.org\/10.1208\/s12249-018-1277-8.","journal-title":"AAPS PharmSciTech."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02592-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-023-02592-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02592-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T23:05:09Z","timestamp":1687475109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-023-02592-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["2592"],"URL":"https:\/\/doi.org\/10.1208\/s12249-023-02592-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"132"}}